Trade Coherus Oncology Inc - CHRS CFD

Trading Conditions

• Type: CFD
• Spread: 0.05
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 1.59
• Open: 1.56
• 1-Year Change: 73.33%
• Day's Range: 1.5 - 1.59

What is Coherus Oncology Inc (CHRS)?

Coherus Oncology Inc is a biopharmaceutical company focused on the development and commercialization of biosimilar and novel oncology therapies. It aims to provide treatments that address various forms of cancer by leveraging biologic technologies and clinical research. The company's portfolio includes biosimilar versions of established cancer drugs, intended to offer cost-effective alternatives to branded therapies. Its research efforts encompass both biosimilars and innovative molecules targeting specific cancer pathways. The company operates within the pharmaceutical industry, collaborating with healthcare providers and regulatory agencies to bring therapies to market. Its activities include clinical trials, regulatory submissions, and manufacturing processes aligned with industry standards. The company’s mission centers on expanding access to cancer treatments through scientific innovation and strategic development.

Coherus Oncology Inc Stock Price Today: Live Overview

The price today is shaped by current trading movements as Coherus Oncology Inc trades at $1.55. Throughout the session, prices ranged from $1.5 to $1.6, reflecting a change of 0%.

FAQ: Coherus Oncology Inc (CHRS)

What is the current price of CHRS stock?

The current price is $1.55.

Does CHRS pay dividends?

Coherus Oncology Inc does not currently pay dividends.

Does CHRS have a formal corporate presence or regional headquarters in the UAE?

Coherus Oncology Inc has a registered presence in the UAE through a subsidiary located in Dubai Internet City.

What is CHRS best known for?

Coherus Oncology Inc is most famous for its development and commercialization of biosimilar oncology drugs.

What assets are typically shown together with CHRS?

Commonly shown alongside CHRS: Axon Enterprise Inc, Editas Medicine, C4 Therapeutics, Inc.